Solak O, Sayar A, Metin M, Erdoğu V, Cuhadaroğlu S, Turna A, Gürses A
Yedikule Hospital for Chest Diseases and Thoracic Surgery, Department of Thoracic Surgery, Istanbul, Turkey.
Acta Chir Belg. 2005 Apr;105(2):180-2.
Mediastinal lymph node enlargement in operable non-small cell lung cancer is of clinical importance since it indicates the high possibility of nodal metastasis. The coincidence of tuberculosis and lung cancer is detected by the mediastinal lymph node staging of lung cancer patients. In our study, we retrospectively re-evaluated the records of patients who had been hospitalized with the diagnosis of lung cancer for the past 10 years. The mean age was 58 +/- 10 years (ranging from 39 to 72). A tuberculous lymphadenitis was detected in 16 of the 315 (5.1%) patients in one and/or multiple stations by either mediastinoscopy or thoracotomy. Inferior paratracheal lymph nodes (4R-4L) were the most frequently affected. None of the patients had a history of primary tuberculosis infection. The cell type was squamous cell carcinoma in ten patients (62.5%) and adenocarcinoma in six patients (37.5%). The tumour was located in the right lung in nine patients (56.2%). The most frequently involved site was the right upper lobe (n = 13, 81.2%). N2 disease was detected in six patients (37.5%). Our study showed that 5.1% of lung patients had tuberculous lymphadenitis coincidentally. The diagnosis and treatment of this latent disease could be considered as important, especially in lung cancer patients who would potentially receive radiotherapy or chemotherapy which alters the immune system. However, the real value of this finding needs further study.
可手术切除的非小细胞肺癌出现纵隔淋巴结肿大具有重要临床意义,因为这表明存在淋巴结转移的高可能性。通过肺癌患者的纵隔淋巴结分期可发现肺结核与肺癌的并存情况。在我们的研究中,我们回顾性地重新评估了过去10年因肺癌诊断而住院的患者记录。平均年龄为58±10岁(范围从39岁至72岁)。在315例患者中的16例(5.1%)通过纵隔镜检查或开胸手术在一个和/或多个部位检测到结核性淋巴结炎。气管旁下淋巴结(4R-4L)是最常受累的部位。所有患者均无原发性结核感染史。细胞类型为鳞状细胞癌的患者有10例(62.5%),腺癌患者有6例(37.5%)。肿瘤位于右肺的患者有9例(56.2%)。最常累及的部位是右上叶(n = 13,81.2%)。6例患者(37.5%)检测到N2期疾病。我们的研究表明,5.1%的肺癌患者同时合并有结核性淋巴结炎。对于这种潜在疾病的诊断和治疗应予以重视,特别是对于可能接受放疗或化疗从而改变免疫系统的肺癌患者。然而,这一发现的实际价值需要进一步研究。